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A B S T R A C T   
Introduction: Coronavirus 2019 (COVID-19) has been associated with endothelial dysfunction. This hypercoag-
ulable state coming from the endothelial injury pones COVID-19 patients to a higher risk for thrombosis. COVID 
19 diabetic patients are more exposed to peripheral vascular disease progression. Multilevel peripheral arterial 
disease is the main cause of critical limb ischemia. Vascular interventions are required to increase distal blood 
flow and reduce the risk of amputation. 
Presentation of case: We report a case of complex revascularization in a diabetic patient with aggressive right foot 
lesions evolution after COVID-19 infection. The patient presenting a Peripheral arterial ischemic involving the 
infrarenal aorta, iliac, femoral. The simultaneous intervention consisted of an endovascular aortic stent-graft 
placement and angioplasty of femoral artery. 
Discussion: Diabetes is a risk factor of severity and deaths in patients infected with pulmonary viruses. In our 
experience, COVID 19 virus can accelerate the ulcers generation and progression in diabetic patient. Hybrid 
interventions can be performed simultaneously or staged with benefit given by the complementary role of 
endovascular and surgical treatments. In the reported case, a complex simultaneous treatment in a patient 
presenting Multilevel peripheral arterial disease in association to COVID 19 infection was feasible in the same 
operation. 
Conclusion: Hybrid procedures are safe with high degree of efficacy in terms of revascularization, reduced 
morbidity and shorter intensive care. In our experience, the use of a hybrid procedure is technically feasible and 
allowed the treatment of complicated diabetic COVID-19 patient with a good outcome.   
1. Introduction 
Multilevel peripheral arterial disease (PAD) in diabetic patients, is 
one of the most frequent causes of amputation. After major lower- 
extremity amputation, the cumulative mortality rate at 1 year is high 
to 30.7% [1]. The actual severe acute respiratory syndrome coronavirus 
2 (SARS-CoV-2) pandemic, has proven to have a significant role in the 
development of vascular events due to coagulative alteration related to 
excessive inflammation, platelet activation, endothelial dysfunction, 
and stasis [2]. 
Vascular interventions in PAD patients have the role to increase foot 
blood flow enhancing cutaneous oxygen pressure, promoting wound 
healing and reduce ischemic state in lower limbs [3,4]. Here we report a 
case COVID-19 positive diabetic patient with already known multilevel 
PAD, including abdominal aorta, iliac artery and femoral artery. In this 
case, we have chosen a hybrid procedure including remote simultaneous 
multiple endovascular procedures from a surgical exposed common 
femoral artery to address multiple vascular lesions. 
This work has been written in accordance with the SCARE criteria 
[5]. 
2. Case report 
A 56-years-old woman with history of hypertension, decompensated 
diabetes mellitus, was referred to our hospital with critical limb 
ischemia (CLI) presenting rest pain and ulcer on the left leg and negative 
COVID-19. On physical examination, her blood pressure was 160/90 
mmHg with 130 b/m. Auscultation of the abdomen revealed a meso-
gastrium systolic bruit. Electrocardiogram showed signs of ST segment 
depression without thoracic pain. Coronary angiography was positive 
for severe coronary artery disease with no indication to treatment. 
Duplex ultrasound (DUS) revealed widespread irregularities of the aortic 
wall with monophasic wave on right common femoral artery and direct 
flow on the left femoral axis; diffuse disease of both superficial femoral 
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arteries (SFA) with distal occlusion in the left side. 
CT-scan showed atherosclerotic disease on infrarenal abdominal 
aorta with focal dissection, occlusion of right common iliac artery origin 
and short dissection of the left common iliac artery origin not hemo-
dynamically significative (Fig. 1). 
The presence of ulcers in the left leg was the indication to address the 
left SFA throughout an antegrade percutaneous homolateral access with 
drug eluting balloon (DEB) angioplasty in the proximal SFA (6.0 × 60 
mm Luminor®; iVascular, Vascular S.L.U., Barcelona, Spain) and distal 
stenting (5.0x80mm iVolution; iVascular) (Fig. 2). The final result was a 
complete lesion healing in the left foot at three weeks (Fig. 3). 
After two months of the index procedure, the patient was readmitted 
due to gangrene of the right foot and asymptomatic COVID-19 infection. 
The control CT showed a similar vascular pattern on the right side with 
no significant difference with the previous CT. At this stage, the rapid 
and aggressive right foot lesions evolution was the indication to address 
vascular lesions in the right axis. 
The intervention was carried under general anesthesia with surgical 
exposure of both common femoral arteries employed as remote accesses 
for multilevel endovascular intervention. The first step consisted of 
aorto-iliac repair (aortic dissection and right common iliac occlusion) 
using an AFX aortic endograft (Endoogix Inc., Irvine, CA, USA); stenting 
of the right common iliac artery (balloon expandable stent - Isthmus 10 
× 39; CID SpA, Saluggia, Italy). 
During the same operation, the right SFA disease was addressed with 
a DEB (Luminor 5 × 200 iVascular) (Fig. 4). The multiple intervention 
determined the increase of the distal flow and the reappearance of 
dorsalis pedis pulse. After two days, the patient was asymptomatic for 
right foot pain and underwent to right foot minor amputation. The pa-
tient was discharged after a week with double antiplatelet therapy. CT 
angiography performed after two months confirmed the proper posi-
tioning of the aortic stent-graft with good patency of iliac-femoral axis 
and right foot ulcers healing (Fig. 5). 
3. Discussion 
The World Health Organization, on March 11, 2020, declared the 
SARS-CoV-2 an official pandemic. Thromboembolic complications, 
including pulmonary embolism (PE), peripheral venous and arterial 
thrombosis, and acute stroke (seen also in patients older than 50 years 
without risk factors) have been already reported [6]. 
Recent studies suggest that dysfunction of the endothelium during 
COVID-19 may exacerbate these deleterious events by inciting inflam-
matory and microvascular thrombotic processes. Endothelial dysfunc-
tion is also a common denominator in reported COVID-19 comorbidities. 
A case series of 5700 hospitalized COVID-19 patients reported that hy-
pertension, obesity, and diabetes are the most common comorbidities, 
all of which involve underlying endothelial damage. Together, major 
clinical events in severe COVID-19 patients, laboratory evidence of 
endothelial dysfunction associated with poor prognosis, and reported 
comorbidities all support that COVID-19 targets endothelial cells [6]. 
Diabetes and uncontrolled glycemia were reported as significant pre-
dictors of severity and deaths in patients infected with different viruses, 
including the 2009 pandemic influenza A (H1N1), SARS-CoV and MERS- 
CoV. In the current SARS-CoV-2 pandemic, some studies did not find a 
clear association between diabetes and severe disease. However, other 
reports from China and Italy showed that older patients with chronic 
diseases, including diabetes, were at higher risk for severe COVID-19 
and mortality. Diabetes is a chronic inflammatory condition character-
ized by multiple metabolic and vascular abnormalities that can affect 
our response to pathogens. Hyperglycemia and insulin resistance pro-
mote increased synthesis of glycosylation end products and pro- 
inflammatory cytokines, oxidative stress, in addition to stimulating 
the production of adhesion molecules that mediate tissue inflammation. 
This inflammatory process may compose the underlying mechanism that 
leads to a higher propensity to infections, with worse outcomes thereof 
in patients with diabetes [7]. 
However, is common experience that to increase the blood flow to 
the foot which in turn enhances cutaneous oxygen pressure promoting 
infection clearance and ulcer granulation [8,9]. Nowadays the use of 
endovascular therapies as primary treatment in patients with CLI and 
femoro-popliteal lesions is on the rise [10,11]. Infrarenal acute aortic 
syndromes (IAAS) can be managed with the medical, surgical, or 
endovascular approach. The endovascular approach showed better re-
sults with a reduced mortality and morbidity risk when compared to 
conventional open surgery. The main concerns of IAAS endovascular 
treatments are the lack of dedicated devices and the use of standard 
aortic stent-grafts outside the instruction for use (IFU). Different solu-
tions including uncovered stents, covered stents, and stent-grafts have 
been proposed [12]. In literature, among the best commercially avail-
able device adapting to IAAS characteristic was the unibody stent-graft 
system (AFX endovascular AAA system; Endologix Inc.). The bottom-up 
construction of such a device allows its use in small aortic bifurcation 
diameter and short renal to aortic bifurcation distance [13], especially in 
women presenting higher incidence of such anatomia conditions [14]. 
Techniques such as subintimal angioplasty of the femoral-popliteal 
artery segment, retrograde angioplasty using trans-pedal access and 
arterial flossing with anterograde-retrograde intervention are relevant 
technical innovations that improve the percutaneous transluminal an-
gioplasty success rate in the diabetic limb which, as open techniques, 
have the final outcome of increasing distal vascularization. Several 
studies have highlighted the importance of a deep revascularization in 
view of the fact that below the knee revascularization reduces the rate of 
non-healing, minor and major amputations [15]. 
In the reported case, the COVID-19 infection was determinant in 
accelerating the ulcers generation and progression. In our experience, 
Fig. 1. Preoperative CT-angiography showing significant atherosclerotic aortic disease (A and B), right common iliac artery (C) and femoral popliteal axes.  
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Fig. 2. Preoperative CT-angiography showing atherosclerotic disease and occlusion of the left femoral artery (A); intraoperative angiography showing patency of 
superficial femoral artery after PTA with eluting ballon (B) and Stenting (C). 
Fig. 3. Left foot before revascolarizzation (A) and three week after (B).  
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the effectiveness of the revascularization is decisive factor that leads to 
the results to allow a reducing the levels of amputation. 
4. Conclusions 
In literature, COVID-19 is responsible not only for respiratory failure 
but also organ failure by multifactorial etiology with at the base an 
endothelial injury associated with dysfunction of microcirculation. 
COVID-19 in diabetic patient can accelerate the evolution of tissue 
damage. 
Endovascular procedures have been used increasingly often for the 
treatment of multilevel vascular disease in the fragile vascular patient 
population. The results of the treatment seem to be with low morbidity. 
In our limited experience, the use of an endovascular approach for 
treatment of a complicated atherosclerotic peripheral decease in dia-
betic COVID-19 patient was safe and technically feasible with decrease 
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